Spotlight: Can the production of iPSC-derived beta islets for Type I diabetes be scaled up to be commercially viable?

Name: Spotlight: Can the production of iPSC-derived beta islets for Type I diabetes be scaled up to be commercially viable?
Start: 2027-01-19T11:30
End: 2027-01-19T11:45
Location: San Diego Convention Center

Advanced Therapies Week 2027 · 19 January 2027 · 11:30–11:45 · Theatre 2

Spotlight: Can the production of iPSC-derived beta islets for Type I diabetes be scaled up to be commercially viable? was a session at Advanced Therapies Week 2027 on 19 January 2027 in San Diego, with 1 speaker on record.

Speakers

Greg Russotti — Speaker Chief Technology & Manufacturing Officer, Century Therapeutics